据华尔街日报:美国食品药品监督管理局(FDA)错过了有关新冠疫苗决定的最后期限。FDA的领导目前正搁置这一决定,并表示诺瓦瓦克斯医药(NVAX.O)的应用需要更多的数据。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.